Kaletra 20 mg/mL (Lopinavir and Ritonavir SOLUTION) 20 mg/mL

Kaletra 20 mg/mL is a solution containing lopinavir and ritonavir, used for managing HIV infections. This oral medication is designed to help control the virus in the body.

Strength

20 mg/mL

Pack Size

1 BOTTLE in 1 CARTON (0074-3956-46) / 160 mL in 1 BOTTLE

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kaletra 20 mg/mL is primarily used in the treatment of HIV infection. It combines two antiretroviral drugs, lopinavir and ritonavir, to help manage the virus. This medication is often prescribed as part of a broader treatment plan to control HIV and improve immune function. People may ask, 'What is Kaletra used for?' and the answer is that it is used to manage HIV infections in combination with other therapies.

Side Effects

Common effects of Kaletra 20 mg/mL may include nausea, diarrhea, and headache. Some individuals might experience changes in taste or stomach pain. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Kaletra 20 mg/mL should be handled with care, especially by those with liver or kidney issues. It is important to follow the prescribed dosage and administration instructions. Always store the medication as directed and keep it out of reach of children.

Avoid Interactions

Kaletra 20 mg/mL can interact with various medications, including other antiretrovirals, statins, and certain antibiotics. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

Kaletra 20 mg/mL is used to manage HIV infections as part of a combination therapy.

Kaletra 20 mg/mL is taken orally, typically following the instructions provided by a healthcare professional.

Common side effects may include nausea, diarrhea, and headache. Always consult a healthcare provider for personalized advice.

Kaletra 20 mg/mL can interact with various medications, so it's important to discuss all current medications with a healthcare provider.

Kaletra 20 mg/mL should be stored according to the instructions provided on the packaging, typically at room temperature.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.